Log in to save to my catalogue

Humoral Immune Response to SARS-CoV-2 in Iceland

Humoral Immune Response to SARS-CoV-2 in Iceland

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7494247

Humoral Immune Response to SARS-CoV-2 in Iceland

About this item

Full title

Humoral Immune Response to SARS-CoV-2 in Iceland

Publisher

United States: Massachusetts Medical Society

Journal title

The New England journal of medicine, 2020-10, Vol.383 (18), p.1724-1734

Language

English

Formats

Publication information

Publisher

United States: Massachusetts Medical Society

More information

Scope and Contents

Contents

This large comparative study of the Icelandic population showed that the humoral response did not decline within 4 months after infection, that 44% of persons who had been infected had not been diagnosed with qPCR, and that the infection fatality risk was 0.3%.

Alternative Titles

Full title

Humoral Immune Response to SARS-CoV-2 in Iceland

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7494247

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7494247

Other Identifiers

ISSN

0028-4793

E-ISSN

1533-4406

DOI

10.1056/NEJMoa2026116

How to access this item